» Articles » PMID: 24658836

A Shorter Telomere is the Key Factor in Preventing Cultured Human Mesenchymal Stem Cells from Senescence Escape

Overview
Publisher Springer
Date 2014 Mar 25
PMID 24658836
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Mesenchymal stem cells (MSCs) from various animals undergo spontaneous transformation in vitro,establishing some malignant characteristics. However,this phenomenon seems seldom appearing in human (h)MSCs. To address the question whether the hMSCs really do not undergo the spontaneous transformation and why,the present study compared MSCs from two species under the same conditions, the commercialized primary hMSCs whose in vitro life span is very uniform, and the rat (r)MSCs whose spontaneous transformation in vitro is well defined.It was demonstrated that in rMSCs, there were small numbers of re-proliferating cells appearing after a substantial senescent period. These “senescence-escaped”rMSCs were highly proliferative and did not show any sign of growth arrest during the following subcultures upto observed passage 32. Whereas after entering senescence, hMSCs no longer re-proliferated and finally died from apoptosis. Compared with rMSCs, the hMSCs possessed a much shorter telomere, and lacked both telomerase reverse transcriptase expression and telomerase activity. When proliferating from pre-senescent to senescent stages,the hMSCs had a greater loss of relative telomere length(51 % in hMSC vs. 15 % in rMSC), but both cells displayed a similar average telomere shortening per population doubling (0.50 ± 0.06 kb in rMSC vs. 0.49 ± 0.06 kbin hMSC; p > 0.05), indicating that the greater relative shortening of the hMSC telomeres was due to their original shorter length, rather than lack of telomere maintenance mechanisms. In conclusion, the hMSCs do not spontaneously initiate transformation, because they cannot escape senescence. This is particularly due to their much shorter telomere.

Citing Articles

The Mechanism of Stem Cell Aging.

Mi L, Hu J, Li N, Gao J, Huo R, Peng X Stem Cell Rev Rep. 2022; 18(4):1281-1293.

PMID: 35000109 PMC: 9033730. DOI: 10.1007/s12015-021-10317-5.


Targeting Stem Cells in Chronic Inflammatory Diseases.

van de Vyver M, Powrie Y, Smith C Adv Exp Med Biol. 2021; 1286:163-181.

PMID: 33725353 DOI: 10.1007/978-3-030-55035-6_12.


To Breathe or Not to Breathe: The Role of Oxygen in Bone Marrow-Derived Mesenchymal Stromal Cell Senescence.

Gala D, Fabian Z Stem Cells Int. 2021; 2021:8899756.

PMID: 33519938 PMC: 7817290. DOI: 10.1155/2021/8899756.


Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review.

Christodoulou I, Goulielmaki M, Devetzi M, Panagiotidis M, Koliakos G, Zoumpourlis V Stem Cell Res Ther. 2018; 9(1):336.

PMID: 30526687 PMC: 6286545. DOI: 10.1186/s13287-018-1078-8.


Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse.

Nowakowski A, Drela K, Rozycka J, Janowski M, Lukomska B Stem Cells Dev. 2016; 25(20):1513-1531.

PMID: 27460260 PMC: 5035934. DOI: 10.1089/scd.2016.0120.


References
1.
Moioli E, Hong L, Guardado J, Clark P, Mao J . Sustained release of TGFbeta3 from PLGA microspheres and its effect on early osteogenic differentiation of human mesenchymal stem cells. Tissue Eng. 2006; 12(3):537-46. PMC: 4035024. DOI: 10.1089/ten.2006.12.537. View

2.
Garcia S, Bernad A, Martin M, Cigudosa J, Garcia-Castro J, De La Fuente R . Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res. 2010; 316(9):1648-50. DOI: 10.1016/j.yexcr.2010.02.016. View

3.
Aisner D, Wright W, Shay J . Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev. 2002; 12(1):80-5. DOI: 10.1016/s0959-437x(01)00268-4. View

4.
Furlani D, Li W, Pittermann E, Klopsch C, Wang L, Knopp A . A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant. 2009; 18(3):319-31. DOI: 10.3727/096368909788534906. View

5.
Cherif H, Tarry J, Ozanne S, Hales C . Ageing and telomeres: a study into organ- and gender-specific telomere shortening. Nucleic Acids Res. 2003; 31(5):1576-83. PMC: 149817. DOI: 10.1093/nar/gkg208. View